Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
Completed
Subjects who qualify for participation will receive lenalidomide with or without dexamethasone in 4 week cycles until disease progression is documented or lenalidomide becomes commercially available for the indication of multiple myeloma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/10/2010
Locations: Alta Bates Cancer Center, Berkeley, California +5 locations
Conditions: Multiple Myeloma
Comparison of Oral Dexamethasone Doses in Asthma Exacerbation
Completed
Hypothesis: A 2-day course of oral dexamethasone is the superior option for the resolution of symptoms and prevention of relapse in the emergency department (ED) management of mild-moderate asthma exacerbations.
Gender:
ALL
Ages:
Between 2 years and 17 years
Trial Updated:
07/17/2009
Locations: Rady Children's Hospital, San Diego, California
Conditions: Asthma, Reactive Airway Disease